Literature DB >> 30383448

CD8+, but not CD4+ effector/memory T cells, express the CD44highCD45RBhigh phenotype with aging, which displays reduced expression levels of P2X7 receptor and ATP-induced cellular responses.

Amine Mellouk1, Pierre Bobé1.   

Abstract

Previously we reported that the sensitivity of CD4+ T cells to ATP does not depend on P2X7 receptor (P2X7R) expression levels but on their activation and differentiation stages. Therefore, here we have investigated a potential relationship between the sensitivity of CD8+ T cells to ATP and their stages of differentiation. Thus, the CD8+ subpopulation exhibits a drastically reduced sensitivity to ATP with aging, which parallels the strong increase of an effector/memory CD8+ subset expressing high levels of CD44 cell adhesion molecule and CD45RB transmembrane phosphatase (CD44hiCD45RBhi). Using l-selectin/CD62L, CC-chemokine receptor 7, and CD127/IL-7 receptor-α markers, we showed that effector/memory CD8+ T cells belong to a central or effector memory subset. In contrast, the CD44hiCD45RBhi effector/memory subset is absent or poorly expressed in the CD4+ T subpopulation regardless of age. While ATP treatment can trigger channel and pore formation, CD62L shedding, phosphatidylserine exposure, and cell death in the CD44loCD45RBhi-naive CD8+ subset, it is unable to induce these cellular activities in the CD44hiCD45RBhi effector/memory CD8+ subset. Importantly, both CD44loCD45RBhi-naive and CD44hiCD45RBhi effector/memory subsets express similar low levels of P2X7R, demonstrating that the sensitivity of CD8+ T cells to ATP depends on the stage of differentiation instead of P2X7R expression levels.-Mellouk, A., Bobé, P. CD8+, but not CD4+ effector/memory T cells, express the CD44highCD45RBhigh phenotype with aging, which displays reduced expression levels of P2X7 receptor and ATP-induced cellular responses.

Entities:  

Keywords:  T lymphocyte; naive T lymphocyte; purinergic signaling

Mesh:

Substances:

Year:  2018        PMID: 30383448     DOI: 10.1096/fj.201800867R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  5 in total

1.  Aging-dependent mitochondrial dysfunction mediated by ceramide signaling inhibits antitumor T cell response.

Authors:  Silvia Vaena; Paramita Chakraborty; Han Gyul Lee; Alhaji H Janneh; Mohamed Faisal Kassir; Gyda Beeson; Zachariah Hedley; Ahmet Yalcinkaya; M Hanief Sofi; Hong Li; Monica L Husby; Robert V Stahelin; Xue-Zhong Yu; Shikhar Mehrotra; Besim Ogretmen
Journal:  Cell Rep       Date:  2021-05-04       Impact factor: 9.995

Review 2.  P2X7 Receptor at the Crossroads of T Cell Fate.

Authors:  Elizabeth Rivas-Yáñez; Carlos Barrera-Avalos; Brian Parra-Tello; Pedro Briceño; Mariana V Rosemblatt; Juan Saavedra-Almarza; Mario Rosemblatt; Claudio Acuña-Castillo; María Rosa Bono; Daniela Sauma
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

3.  Hypercholesterolemia Negatively Regulates P2X7-Induced Cellular Function in CD4+ and CD8+ T-Cell Subsets from B6 Mice Fed a High-Fat Diet.

Authors:  Tom Hutteau-Hamel; Amine Mellouk; Nicolas Trainel; Anne-Marie Cassard; Pierre Bobé
Journal:  Int J Mol Sci       Date:  2022-06-16       Impact factor: 6.208

4.  P2X7 purinergic receptor plays a critical role in maintaining T-cell homeostasis and preventing lupus pathogenesis.

Authors:  Amine Mellouk; Tom Hutteau-Hamel; Julie Legrand; Hanaa Safya; Mohcine Benbijja; Françoise Mercier-Nomé; Karim Benihoud; Jean M Kanellopoulos; Pierre Bobé
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

5.  Type 1 Cytotoxic T Cells Increase in Placenta after Intrauterine Inflammation.

Authors:  Jin Liu; Yang Liu; Snigdha Panda; Anguo Liu; Jun Lei; Irina Burd
Journal:  Front Immunol       Date:  2021-09-08       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.